Fluocinolone Acetonide
Showing 1 - 25 of 217
Radiation Retinopathy, Visual Impairment Trial (Faricimab, fluocinolone acetonide)
Not yet recruiting
- Radiation Retinopathy
- Visual Impairment
- Faricimab
- fluocinolone acetonide
- (no location specified)
Apr 25, 2023
Imaging of Uveitis Patients Receiving Injectable Fluocinolone
Recruiting
- Uveitis
- Fluocinolone Acetonide
-
Cleveland, OhioCole Eye Institute Cleveland Clinic Foundation
Apr 27, 2022
Diabetic Macular Edema Trial in Dijon (Dexamethasone intravitreal implant, Fluocinolone Acetonide Intravitreal Implant)
Recruiting
- Diabetic Macular Edema
- Dexamethasone intravitreal implant
- Fluocinolone Acetonide Intravitreal Implant
-
Dijon, FranceCHU Dijon-Bourgogne
Apr 28, 2022
Uveitis, Uveitis, Posterior, Uveitis, Intermediate Trial in Waltham (Sham Injector, FAI Insert)
Active, not recruiting
- Uveitis
- +2 more
- Sham Injector
- FAI Insert
-
Waltham, MassachusettsEyePoint Study Site
Dec 20, 2022
Macular Edema After AcF Implant's Injection, 1 Month After Last
Not yet recruiting
- Macular Edema
- ACF injection
- (no location specified)
Aug 10, 2023
Melasma Trial in Karachi (TAM formula (hydroquinone 2%, tretinoin 0.05% and 5% vitamin C), Kligman formula (hydroquinone 4%,
Active, not recruiting
- Melasma
- TAM formula (hydroquinone 2%, tretinoin 0.05% and 5% vitamin C)
- Kligman formula (hydroquinone 4%, fluocinolone acetonide 0.01% and tretinoin 0.05%)
-
Karachi, Sindh, PakistanJPMC
Aug 25, 2023
Uveitis, Posterior Trial in United States (Fluocinolone Acetonide Intravitreal Implant 0.18 mg)
Recruiting
- Uveitis, Posterior
- Fluocinolone Acetonide Intravitreal Implant 0.18 mg
-
Phoenix, Arizona
- +16 more
Aug 18, 2022
YUTIQ® 0.18 mg Intravitreal Implant for Management of Chronic
Recruiting
- Uveitis
- YUTIQ
-
Tianjin, Tianjin, ChinaTianjin Medical University Eye Hospital
Oct 23, 2022
Melasma Trial in Los Angeles, Dallas (Fluocinolone acetonide .1%, hydroquinone 4%, tretinoin .05%)
Completed
- Melasma
- Fluocinolone acetonide .1%, hydroquinone 4%, tretinoin .05%
-
Los Angeles, California
- +1 more
Jul 28, 2022
Radiation Retinopathy Trial in Cleveland (Fluocinolone Acetonide (FA) implant)
Withdrawn
- Radiation Retinopathy
- Fluocinolone Acetonide (FA) implant
-
Cleveland, OhioCole Eye Instiute
Aug 2, 2021
Acute Otitis Externa Trial in Shanghai (Ciprofloxacin-Fluocinolone Acetonide, 0.3%-0.025% Otic Solution, Ciprofloxacin 0.3%
Not yet recruiting
- Acute Otitis Externa
- Ciprofloxacin-Fluocinolone Acetonide, 0.3%-0.025% Otic Solution
- Ciprofloxacin 0.3% solution
-
Shanghai, ChinaEye & Ent Hospital of Fudan University
Nov 13, 2020
Diabetic Macular Edema (DME) Trial in United States (ILUVIEN 0.19 MG)
Completed
- Diabetic Macular Edema (DME)
- ILUVIEN 0.19 MG
-
Phoenix, Arizona
- +40 more
Jan 10, 2022
Non-Infectious Uveitis Trial in Worldwide (FAI insert, Sham injection)
Completed
- Non-Infectious Uveitis
- FAI insert
- Sham injection
-
Beverly Hills, California
- +33 more
Mar 5, 2021
Uveitis Affecting the Posterior Segment Trial in Durham (Fluocinolone Acetonide)
Completed
- Uveitis Affecting the Posterior Segment
- Fluocinolone Acetonide
-
Durham, North CarolinaDuke Eye Center
Dec 18, 2019
Posterior Uveitis, Intermediate Uveitis, Panuveitis Trial in India (Sham Injection, FAI Insert)
Completed
- Posterior Uveitis
- +2 more
- Sham Injection
- FAI Insert
-
Hyderabad, Andhra Pradesh, India
- +14 more
Jul 10, 2020
Non-Infectious Uveitis Trial in United States (FAI Insert administered using the Mk II inserter, FAI Insert administered using
Completed
- Non-Infectious Uveitis
- FAI Insert administered using the Mk II inserter
- FAI Insert administered using the Mk I inserter
-
Colorado Springs, Colorado
- +5 more
Apr 22, 2020
Corneal Endothelial Cell Density in HadFluocinolone Acetonide
Completed
- Inflammation
- Uveitis
- Fluocinolone Acetonide 0.59 mg
- Fluocinolone Acetonide 2.1 mg
-
Boston, MassachusettsOphthalmic Partners of Boston
Jun 20, 2019
Corneal Endothelial Cell Density in Eyes Treated
Completed
- Uveitis, Posterior
- Retisert
- Fluocinolone Acetonide Intravitreal Implant
-
Boston, MassachusettsValeant Site 001
Jun 20, 2019
Oral Lichen Planus Trial (6-Gingerol, Triamcinolone Acetonide 0.1% Oromucosal Paste)
Not yet recruiting
- Oral Lichen Planus
- 6-Gingerol
- Triamcinolone Acetonide 0.1% Oromucosal Paste
- (no location specified)
May 22, 2023
Diabetic Macular Edema Trial in United States (Iluvien 0.19 MG Drug Implant, Aflibercept)
Recruiting
- Diabetic Macular Edema
- Iluvien 0.19 MG Drug Implant
- Aflibercept
-
Phoenix, Arizona
- +45 more
Jan 4, 2022
Diabetic Macular Edema, Diabetes Trial (Iluvien 0.19 MG Drug Implant, Ranibizumab Injection [Lucentis], Sham Intravitreal
Withdrawn
- Diabetic Macular Edema
- Diabetes
- Iluvien 0.19 MG Drug Implant
- +2 more
- (no location specified)
Jun 25, 2019
Uveitis, Uveitis, Posterior, Uveitis, Anterior Trial in Plano (Yutiq 0.18 MG Drug Implant, Sham Injection)
Not yet recruiting
- Uveitis
- +3 more
- Yutiq 0.18 MG Drug Implant
- Sham Injection
-
Plano, TexasTexas Retina Associates
Aug 3, 2022
Psoriasis Vulgaris Trial in Odense C (Improved support by health-care professionals)
Active, not recruiting
- Psoriasis Vulgaris
- Improved support by health-care professionals
-
Odense C, DenmarkDepartment of Dermatology and Allergy Centre
Sep 7, 2021
Rapid Structural and Functional Improvements in Following 0.19
Unknown status
- Diabetic Macular Edema
- 0.19 mg fluocinolone acetonide (FAc) implant
-
Abu Dhabi, United Arab EmiratesShiekh Khalifa medical city
Jul 7, 2018
Erosive Lichen Planus Trial in Alexandria (Lycopene Softgel, 10 Mg, Prednisolone)
Completed
- Erosive Lichen Planus
- Lycopene Softgel, 10 Mg
- Prednisolone
-
Alexandria, EgyptFaculty of Dentistry, Alexandria University
Nov 26, 2020